Auricular Acupuncture for Analgesia During Total Hip Arthroplasty

NCT ID: NCT00334165

Last Updated: 2011-02-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2/PHASE3

Total Enrollment

360 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-06-30

Study Completion Date

2008-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim is to investigate whether auricular acupuncture is superior to sham acupuncture in relief of acute pain and in reduction of analgesics in patients during total hip arthroplasty

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Pain Total Hip Arthroplasty

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Auricular acupuncture (procedure)

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients with an American Society of Anesthesiologists physical status of I to III scheduled for elective hip arthroplasty because of degenerative osteoarthritis under general anesthesia.
2. Surgery time does not exceed 100 minutes.
3. Patients without previous opioid medication.
4. Patients ranged 45-85 years old.
5. Patients who have given informed consent.

Exclusion Criteria

1. Pregnant or nursing females.
2. Recidivist alcoholics.
3. Local or systemic infection.
4. Age \< 45 and \> 85 years.
5. Surgery time more than 100 minutes.
6. Intraoperative complications (bleeding, required blood transfusion more than 4 units of packed cells , cardiovascular instability, required catecholamines).
7. Patients consumed opioid medication before surgery.
8. Patients with prosthetic or damaged cardiac valves.
9. Patients who are unable to understand the consent form.
10. History of psychiatric disease.
Minimum Eligible Age

45 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Humboldt-Universität zu Berlin

OTHER

Sponsor Role collaborator

University Medicine Greifswald

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Taras I Usichenko, M.D.

Role: STUDY_CHAIR

Ernst Moritz Arndt University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Berlin, Campus Charite

Berlin, , Germany

Site Status

Ernst Moritz Arndt University

Greifswald, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

III UV 13/05

Identifier Type: -

Identifier Source: org_study_id